Summary. The presence of one of the major targets for autoantibodies in Type 1 (insulin-dependent) diabetes mellitus, the enzyme glutamic acid decarboxylase, was studied in human, rat and mouse pancreatic tissue using immunoprecipitation and immunohistochemical techniques. Immunoprecipitation of glutamic acid decarboxylase was attempted with lysates of [35S]-methionine-labelled rat or mouse pancreatic islets using two different glutamic acid decarboxylase antisera, one mouse monoclonal antibody raised against the 65 kDa isoform of the enzyme, sera from six patients with Type 1 diabetes, one patient with stiff-man syndrome and sera from 19 non-obese diabetic mice. The same sera were used for immunoperoxidase staining of cryosections of human, rat or mouse pancreas. Using patient sera glutamic acid decarboxylase was detected by immunoprecipitations from isolated rat islets but not from islets of five different mouse strains tested, including the non-obese diabetic mouse. When using the non-obese diabetic mouse sera, glutamic acid decarboxylase could not be detected in either rat or mouse tissue. Immunoperoxidase staining demonstrated high levels of glutamic acid decarboxylase in human and rat pancreatic islets but low levels in mouse islets. Direct measurements of enzyme activity showed glutamic acid decarboxylase to be present in mouse islets at a level of about 40 % of that in rat islets, and subsequent Western blot analyses indicated that mouse islets express the 67 kDa isoform, whereas in rat islets both the 67 and 65 kDa isoforms are present. The species difference at the level of one of the major islet cell autoantigens in Type I diabetes thus indicates that human or rat and mouse islets, respectively, express immunologically distinct forms of glutamic acid decarboxylase and differ in their way of regulating the enzyme production.
The destruction of insulin-producing beta cells precedes the clinical onset of Type 1 (insulin-dependent) diabetes mellitus and is believed to be caused by autoimmune mechanisms [1] . These mechanisms include lymphocytic infiltration of islets and the formation of autoantibodies. Sera of patients with recent-onset Type I diabetes often contain antibodies recognizing a 64 kDa protein [2] , recently shown to be identical to the gamma-aminobutyric acid (GABA)-synthesizing enzyme glutamic acid decarboxylase (GAD) [3] . Apart from GAD, sera of patients with Type I diabetes also react with other islet cell antigens. Thus, an antigen of presumed glycolipid nature [1] , islet cell surface antigens [4] , as well as a "diabetes associated protein" [5] have been described. The molecular characteristics of these antigens, which appear unrelated to GAD, remain unknown. A commonly used animal model for Type 1 diabetes is the non-obese diabetic (NOD) mouse, a strain in which the animals become diabetic in varying frequences in different colonies between 80 and 200 days of age [6] . Although there is a female preponderance of disease, this model is generally regarded to be more representative of the human disease than the BB rat model [1] . It would therefore be of interest to examine the regulation of GAD-synthesis and the development of diabetes in the NOD-mouse. Autoantibodies to a 64 kDa protein have been reported previously in sera from NOD mice using labelled mouse islet cells as the antigen source [7] . However, we unexpectedly failed in our initial immunoprecipitation experiments with human sera, to positively identify the doublet of 64 kDa [8] on sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) from [35S]-methionine labelled NOD mouse islets [9] . In the present study we therefore examined the presence of GAD in mouse islets prepared from several different strains, using immunoprecipitation techniques as well as immunoperoxidase staining of mouse, rat and human pancreas sections. To control the reactivity of our different sera, mouse cerebellar tissue methionine-labelled lysates of NOD (a-e) and NMRI (f-j) mouse islets, respectively. Different sera from patients with newly-onset Type 1 (insulin-dependent) diabetes (b~l and g-i) fail to immunoprecipitate the 64 kDa/GAD-doublet. A rabbit serum against the MHC class I was used as positive control (a and f). A serum from a healthy control subject (e and j) was also included k n o w n to c o n t a i n G A D [10] was also examined. Further, G A D enzymatic activity was m e a s u r e d in lysates of rat and m o u s e islets a n d the possible presence of the two different isoforms, the 67 k D a a n d 65 kDa, first described in experiments with b r a i n tissue [11] , was e x a m i n e d by Western blot analysis using islet lysates a n d isoform specific antibodies.
Materials and methods
Islets from either mice or rats were manually isolated from collagenase-digested pancreas [12] . The animal strains used were WistarFurth rats, aged 12 to 16weeks (ALAB, Sollentuna, Sweden), NMRI mice (ALAB), C57BL/6 (ob/ob) and C57BL/6 ( +/?) mice, both belonging to a local inbred strain originally obtained from the Jackson Laboratory (Bar Harbor, Me., USA), Balb/c (Bomholtg~rd, Ltd. Ry, Denmark) and 6-to 8-week-old NOD mice. The NOD mouse colony was established in Uppsala in March 1988 by brother and sister mating of the offsprings from three breeding pairs of inbred NOD mice obtained from the Clea company (Aobodi, Japan). The cumulative incidence of diabetes in the colony at 28 weeks of age is 47 % for the females and 7 % for the males [13] . Isolated islets were either used immediately upon isolation or cultured free floating for 3 days in RPMI-1640 medium (Seromed, Biochrom KG, Berlin, FRG) adjusted to 28 mmol/1 glucose and supplemented with 10 % newborn calf serum (Gibco BRL, Laboratoriedesign, Liding/5, Sweden), 100 U/ml penicillin and 100 gg/ml streptomycin [14] . For internal labelling, typically 500 isolated islets were incubated with [35S]-methionine (> 800 Ci/mmol, New England Nuclear, Boston, Mass., USA) in methionine-free RPMI 1640 with 28 mmol/1 glucose for 6 h. This glucose concentration has been found to increase the biosynthesis of the 64 kDa/GAD protein in rat pancreatic islets [8] .
After incubation, islets were washed twice in ice-cold RPMI-1640 medium without calf serum and subsequently lysed at 4~ in 20 mmolfl Tris-HC1 buffer (pH 7.4) containing 0.15 mol/1NaC1, 1% (vol/vol) Triton X-100, 2 mm01/1 phenylmethylsulphonyl fluoride and 1% (vol/vol) Trasylol (Bayer, Leverkusen, FRG). Insoluble material was removed by centrifugation at 100,000 • g for 60 rain at 4 ~ The lysates were pre-cleared overnight at 4 ~ with pre-immune control serum and subsequently incubated in equal aliquots for 24 h with the different antisera used. Immunoprecipitates were treated as described [8] . SDS-PAGE was carried out on 9-14 % gradient slab gels according to Blobel and Doberstein [15] .
To determine (pro)insulin and total protein biosynthesis, groups of 60 islets were isolated from NMRI mice and Wistar-Furth rats and cultured for 24 h in RPMI-1640 containing 28 mmol/1 glucose. After this period, duplicate groups of 20 islets each were incubated for 2 h at 37 ~ in a Krebs-Ringer bicarbonate buffer containing 28 mmol/1 glucose and L-[4.5.-3H]-leucine (Amersham International, Amersham, Bucks, UK), and the islet (pro)insulin and total protein biosynthesis determined as previously described [13] .
Cryostat sections of unfixed Wistar-Furth rat or NMRI mouse pancreas or cerebellar tissue were stored at -70 ~ before use. Mild fixation was performed at 4 ~ in 50 % (vol/vol) acetone for 30 s and then in 100 % acetone for 5 min. After air-drying at room temperature the sections were rinsed in phosphate buffered saline (PBS) for 5 min, incubated in 0.3 % H202 for 15 min and again rinsed in PBS. Sera from patients with newly-onset Type 1 (insulindependent) diabetes precipitate the 64 kDa doublet in rat (f and g) but not mouse (b and c). A rabbit serum against the MHC class I was used as positive control (a and e). A serum from a healthy control person (d and h) was also included Incubation with normal rabbit serum for 5 min at room temperature preceded the incubation with patient sera (50 gl) for 24 h at 4 ~ Following PBS washing, each section was covered with a 1:200 dilution of peroxidase-conjugated rabbit anti-human, anti-rabbit or antisheep IgG antibody (DAKO-immunoglobulins A/S, Denmark) and the incubation was continued for another 30 min at room temperature. After washing the chromogenic reaction was started by addition of a mixture containing 10 mg 3-amino-9-ethylcarbazol dissolved in 6 ml dimethyl sulphoxide, 50 ml 0.02 mol/l NaAc pH 5.5 and 4 ~130% H202. The reaction was continued for 15 min at room temperature. Following washing, the slides were stained with haematoxylin. Cryostat sections of unfixed human pancreas from cadaveric kidney donors were employed, using an indirect immunofluorescence technique, to identify Type i diabetic sera with high titres of islet cell antibodies, i.e. sera with more than 80 Juvenile Diabetes Foundation units (JDF-units).
Glutamic acid decarboxylase activity was determined essentially as described [16, 17] . Freshly isolated islets of Wistar-Furth rats and NMRI mice were washed in PBS and homogenized in a buffer containing i mmol/1 2-aminoethyl isothiouronium bromide (Sigma, St. Louis, Mo., USA), i retool/1 EDTA, 0.025 mmol/1 pyridoxalphosphate (Sigma), pH 7.0. Total protein concentration in the homogenate was determined by spectrophotometry. For the assay, 100 gl of the homogenates were incubated in duplicates with 0.375 gCi of [14C] glutamic acid (270 mCi/mmol, Amersham) for 18 h at room temperature. The released [14C] CO2 was absorbed in tilter paper soaked in 1 mol/1 hyamine hydroxide (Sigma) and quantified by liquid scintillation spectrometry.
In Western blot experiments lysates of cultured islets were subjected to SDS-PAGE, blotted onto nitrocellulose_paper and incubated with different antibodies. The procedures for running SDS-PAGE and performing the immunoblotting were as described elsewhere [18] .
Sera from six patients with recent-onset Type 1 diabetes and one patient with stiff-man syndrome were used in the study. Antiserum NIMH 1440 [10] , raised in sheep against purified rat GAD, which reacts against both forms of the enzyme with preference for the 65 kDa isoform was a gift from Dr. I. J.Kopin and co-workers at the Laboratory of Clinical Sciences, NIMH, Bethesda, Md., USA. A rabbit antiserum (K2) against feline GAD 67 kDawas a gift from Dr.
A. Tobin, UCLA, Los Angeles, Calif., USA [19] . The GAD-6 monoclonal antibody [20] was produced in our laboratory by a hybridoma cell line purchased from the Developmental Studies Hybridoma Bank, University of Iowa, USA. Sera from 19 NOD mice aged 10 to 14 weeks, being 10 females and 9 males, were purchased from Bomholtghrd Breeding and Research Centre Ltd., Ry, Denmark. In this colony 70 % of the females and 35 % of the males are diabetic at 15 weeks of age. Rabbit antisera against rat and mouse MHC class I antigens were kindly provided by Prof. L. Rask, University of Agriculture, Uppsala, Sweden.
Results

Immunoprecipitation of the 64 kDa/GAD-protein
In initial e x p e r i m e n t s fresh islets were isolated from N O D and N M R I mice in parallel and labelled with [35S]-methionine for 6 h. T h r e e different patient sera with high titres against the 64 k D a / G A D p r o t e i n did not p r e c i p i t a t e any m a t e r i a l in the m o l e c u l a r range of interest (Fig. 1) . O n the o t h e r hand, M H C class I antigens were easily identified, but p r e s e n t in considerably higher a m o u n t s in N O D islets t h a n in islets isolated f r o m N M R I mice. Such interstrain variation was not o b s e r v e d in further e x p e r i m e n t s using strains other t h a n N O D .
Freshly isolated islets from the three other m o u s e strains C57BL/6 (ob/ob), C57BL/6 ( + / ? ) and Balb/c, were tested in parallel with Wistar-Furth rat islets for the p r e s e n c e of the 64 k D a / G A D p r o t e i n using sera f r o m Type 1 diabetic patients (Fig. 2) . T h e 64 k D a / G A D protein could only be identified in the rat lysates, w h e r e a s equal a m o u n t s of M H C class I antigens w e r e p r e s e n t in b o t h m o u s e a n d rat islets. Subsequently, s e r u m from a stiff-man s y n d r o m e patient as well as the sheep a n t i s e r u m N I M H 1440 were used on m o u s e and rat islet lysates, re- Fig.3 . A sheep serum against purified GAD (e and k), as well as a serum from a patient with stiffman syndrome (d and j) were used to immunoprecipitate the 64 kD a doublet in [35S]-methionine labelled islet lysates from NMRI mice (a-f) and Wistar Furtb rats (g-l). Sera from patients with newly-onset diabetes were also used (a-c and g-i). A rabbit serum against the MHC class I was used as positive control (f and 1) spectively (Fig. 3) . Whereas the 64 k D a / G A D protein was easily and reproducibly precipitated from rat islets using the different sera employed here, it could not be identified in any of the mouse strains. Also after high (28 mmol/1) glucose concentration culture for 3 days we were unable to precipitate the 64 k D a / G A D protein from the mouse islets with any of the sera used, whereas it could be easily identified in rat islets (not shown).
Immunoprecipitations of 6 4 k D a / G A D were attempted using sera of 19 pre-diabetic NOD mice. For that, freshly isolated Wistar-Furth rats and NMRI mice islets were labelled with [35S]-methionine and the lysates used in precipitations with sera of all the animals. Controls with sheep antiserum N I M H 1440, rabbit antiserum K2 and mouse monoclonal antibody GAD-6 were positive in precipitating G A D from rat islets but not from mouse islets. None of the 19 mice sera showed precipitation of specific bands in either rat or mouse tissues (not shown).
Biosynthesis of total protein and (pro)insulin
In order to assess if the observed differences between mouse and rat islets in the immunoprecipitation of the 64 k D a / G A D protein could be due to a large inter-species difference in protein synthesis, (pro)insulin (PI-I) and total protein biosynthesis (TCA) were determined in mouse and rat islets exposed to 28 mmol/1 glucose. The observed PI-I values were 68 + 3 dpm x 103/20 islets x 2 h for mouse, and 65 + 7 dpm x 103/20 islets x 2 h in rat. The T C A values were for mouse islets, 317 + 8 dpm x 103/20 islets x 2 h, and for rat islets 370 _+ 25 dpm x 103/20 islets x 2 h (n = 3, each condition studied in duplicate).
Immunoperoxidase staining of the 64 kDa/GAD-protein
Cryosections of human, rat and mouse pancreatic tissues were immunostained with the sheep antiserum N I M H 1440 using the indirect peroxidase technique. The serum reacted with human (not shown) and rat islets (Fig. 4) with similar intensity. Only very weak staining was found in the mouse islets (Fig. 4) . However, in cryosections from rat and mouse cerebellar tissue, strong GADreactivity was found in the Purkinje cell layer of the cerebellum, at similar levels in both species (Fig. 5) . A similar staining pattern was obtained when antiserum K2 was used. Thus, there was a strong staining of rat and mouse brain tissues, less but positive staining of rat islets and no staining of mouse islets (not shown).
Enzyme measurements and Western blots
Measurements of glutamic acid decarboxylase activity were carried out in five separate experiments with freshly isolated NMRI mouse and Wistar-Furth rat islets. All the experiments were run in duplicates. Rat islets were found to contain about 2.5 times higher enzymatic activity than mouse islets. The means of enzymatic activity from the five experiments were 0.776 ( + 0.138) pmol/h x g protein and 0.326 ( + 0.046) pmol/h x g protein, for rat and mouse respectively.
Subsequently, in immunoblotting experiments, glutamic acid decarboxylase was examined in lysates of cultured rat and mouse islets. Different patterns were seen following incubations with the antisera K2 and 1440. K2 is considered specific for the 67 kDa isoform, whereas the 1440 antiserum is known to react with both the isoforms with a predominance for the 65 kDa component [10, 19] . The staining intensity of glutamic acid decarboxylase components was considerably weaker in mouse islets than that found in rat islets (Fig.6) . Secondly, the 67 kDa isoform, appearing as a double band, was the only isoform found in mouse islets, whereas in rat islets both isoforms were observed, with the 65 kDa isoform being the more abundant. This species difference was further demonstrated with the GAD-6 monoclonal antibody specific for the 65 kDa isoform, which gave a positive band with rat islets lysates but did not react with any 65 kDa isoform of the mouse islets.
Discussion
In this study we report a species difference between mice and rats at the level of one of the major autoantigens in Type 1 diabetes, the 64 kDa/GAD protein in pancreatic islets. In repeated experiments we consistently failed to immunoprecipitate the 64 kDa/GAD protein in pancreatic islets isolated from five different mouse strains when using sera from six different patients with recent-onset Type i diabetes. Precipitations of the MHC class I molecules, used as positive controls in our experiments, showed a relative increase in the N O D mouse islet lysates compared to other mouse strains. This is probably a reflection of an immunopathological process, as suggested by the presence of a mononuclear cell infiltrate around the islets in more than 60 % of the NOD mice at 6 weeks of age [13] . As the experiments for comparison of protein synthesis between rat and mouse islets showed no maj or inter-species difference, the lack of immunoprecipitation of G A D in the mouse islets might be attributed to a very narrow spectrum of epitopes recognized by the patient's antibodies, being able to recognize the rat but not the mouse protein. To further test this, a polyclonal sheep serum raised against purified G A D [10], and expected to have a broader reactivity, was used. Again, a lack of reac- Fig.5 . Indirect immunoperoxidase staining of mouse NMRI (lower panel) and rat WistarFurth (upper panel) cerebellar tissue using a sheep serum against purified GAD tivity against GAD in the mouse islets was observed. Experiments aiming to increase the amount of autoantigen by raising the glucose concentration [8] in the incubation medium, also failed to demonstrate expression of the 64 kDa/GAD protein in mouse islets. This was also the case in islets from 5-month-old obese hyperglycaemic mice, which are constantly exposed to hyperglycaemia and hyperinsulinaemia [21] . Furthermore, indirect immunohistochemistry revealed a marked species difference, with high reactivity against G A D in human and rat pancreatic islets, but very weak staining of mouse islets. Although polyclonal sheep sera are known to exhibit a broad species cross-reactivity, the question could be raised whether the observed difference was only due to lack of cross-reactivity against the mouse GAD, since the sheep serum used here was indeed raised against purified rat GAD. To test this possibility, sections of mouse and rat cerebellum, known to contain G A D [10], were stained and showed the expected staining of t h e Purkinje cell layer with equal intensity in both species.
Thus, these data when taken together, suggest that rat and mouse islets differ greatly in their expression of glutamic acid decarboxylase. By the direct enzyme measurements, we detected glutamic acid decarboxylase activity to be present in mouse islets, but at a level considerably lower than that found in rat islets. Such a difference is in accordance with the immunohistochemical studies reported by Gilon et al. [22] , who found the immunolabelling of islets considerably less intense in mice than in rats. The lower level of G A D in mouse compared to rat islets is in line with the five-times lower amount of G A B A measured in mouse compared to rat islets [23] . Recently, two forms of glutamic acid decarboxylase, GAD 67 kDa and G A D 65 kDa, derived from different genes have been described in experiments with brain tissue [11] . With the use of specific antisera directed against the various isoforms, we found by immunoblotting experiments that mouse and rat islets differ in their GAD reactivity. Using the monoclonal antibody GAD-6, which is specific for GAD 65 kDa isoform and reacts with this component of precipitations performed using N O D mouse sera. O n e might speculate however, that under special conditions, expression of a 65 k D a isoform could be induced in mouse islets as shown by Gerling et al. [26, 27] , where Type 1 diabetic patient sera could precipitate a 64 k D a protein from islets isolated from virus infected mice. Fig. 6 . Western blot analysis of mouse (lanes a, c, and e) and rat (b, d, f) islet lysates reacting with antibodies directed against GAD. The GAD-6 mouse monoclonal antibody, specific for the 65 kDa isoform was used in lanes a and b, the rabbit (K2) antiserum directed against the 67 kDa isoform in lanes c and d, and the sheep serum 1440 reacting with both the 67 and 65 kDa isoforms, although primarily with the 65 kDa component, in lanes e and f rat and h u m a n islets [20] , we did not detect any reactivity in mouse islets. Further, the two different G A D antisera, 1440 and K2, reacted with G A D in mouse and rat islets with different staining patterns, which suggested that mouse islets express only the 67 k D a isoform.
In conclusion, this study shows that there is a marked difference between mouse and rat or h u m a n islets in their content of G A D , a major target of autoimmune attack in h u m a n Type 1 diabetes. H u m a n autoantibodies react primarily with the 65 k D a isoform (Velloso et al. unpublished data) , and in h u m a n islets only the 65 k D a isoform seems to be expressed [24, 25] . The present data indicate that in mouse islets the production of G A D is regulated differently, and suggests that in the N O D mouse the expression of the 65 k D a isoform of G A D is not essential for triggering an autoimmune assault to the beta cells. This fact is supported by our negative findings in the immuno-
